UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 145

Sortiert nach

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study

Lancet neurology, 2011-03, Vol.10 (3), p.230-240

2011

Volltextzugriff (PDF)

Multiple system atrophy: A primary oligodendrogliopathy

Annals of neurology, 2008-09, Vol.64 (3), p.239-246

2008

Volltextzugriff (PDF)

Alpha-synuclein in the appendiceal mucosa of neurologically intact subjects

Movement disorders, 2014-07, Vol.29 (8), p.991-998

2014

Volltextzugriff (PDF)

CNS expression of glucocerebrosidase corrects α-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy

Proceedings of the National Academy of Sciences - PNAS, 2011-07, Vol.108 (29), p.12101-12106

2011

Volltextzugriff (PDF)

Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders

Journal of neurochemistry, 2016-10, Vol.139 (S1), p.290-317

2016

Volltextzugriff (PDF)

Deciphering the role of heterozygous mutations in genes associated with parkinsonism

Lancet neurology, 2007-07, Vol.6 (7), p.652-662

2007

Volltextzugriff (PDF)

Parkin-Dependent Degradation of the F-Box Protein Fbw7β Promotes Neuronal Survival in Response to Oxidative Stress by Stabilizing Mcl-1

Molecular and Cellular Biology, 2013-09, Vol.33 (18), p.3627-3643

2013

Volltextzugriff (PDF)

Parkinson’s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures

Journal of Neural Transmission, 2011-05, Vol.118 (5), p.795-808

2011

Volltextzugriff (PDF)

Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson's disease

Journal of neuroinflammation, 2017-08, Vol.14 (1), p.164-164, Article 164

2017

Volltextzugriff (PDF)

Molecular markers of early Parkinson's disease based on gene expression in blood

Proceedings of the National Academy of Sciences - PNAS, 2007-01, Vol.104 (3), p.955-960

2007

Volltextzugriff (PDF)

GATA transcription factors directly regulate the Parkinson's disease-linked gene α-synuclein

Proceedings of the National Academy of Sciences - PNAS, 2008-08, Vol.105 (31), p.10907-10912

2008

Volltextzugriff (PDF)

Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo

Molecular brain, 2009-02, Vol.2 (1), p.5-5, Article 5

2009

Volltextzugriff (PDF)

Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker Initiative

Neurobiology of disease, 2015-08, Vol.80, p.29-41

2015

Volltextzugriff (PDF)

Genetic and pharmacological reduction of CDK14 mitigates synucleinopathy

Cell death & disease, 2024-04, Vol.15 (4), p.246-246, Article 246

2024

Volltextzugriff (PDF)

DMS as an orthogonal separation to LC/ESI/MS/MS for quantifying isomeric cerebrosides in plasma and cerebrospinal fluid[S]

Journal of lipid research, 2019-01, Vol.60 (1), p.200-211

2019

Volltextzugriff (PDF)

Progressive dopaminergic cell loss with unilateral-to-bilateral progression in a genetic model of Parkinson disease

Proceedings of the National Academy of Sciences - PNAS, 2012-09, Vol.109 (39), p.15918-15923

2012

Volltextzugriff (PDF)

Who Ever Said It Would Be Easy? Reflecting on Two Clinical Trials Targeting α‐Synuclein

Movement disorders, 2023-03, Vol.38 (3), p.378-384

2023

Volltextzugriff (PDF)

Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19

Acta neuropathologica communications, 2024-05, Vol.12 (1), p.70-16, Article 70

2024

Volltextzugriff (PDF)

A First Tetraplex Assay for the Simultaneous Quantification of Total α-Synuclein, Tau, β-Amyloid42 and DJ-1 in Human Cerebrospinal Fluid

PloS one, 2016-04, Vol.11 (4), p.e0153564-e0153564

2016

Volltextzugriff (PDF)

effects of oxidative stress on parkin and other E3 ligases

Journal of neurochemistry, 2007-12, Vol.103 (6), p.2354-2368

2007

Volltextzugriff (PDF)

Unraveling the assembloid: Real-time monitoring of dopaminergic neurites in an inter-organoid pathway connecting midbrain and striatal regions

Materials today bio, 2024-04, Vol.25, p.100992-100992, Article 100992

2024

Volltextzugriff (PDF)

Target‐Specific Strategies to Modify the Course of Parkinson's: Is Iron Chelation Safe?

Movement disorders, 2023-05, Vol.38 (5), p.740-741

2023

Volltextzugriff (PDF)

Neurodegeneration: Impact of S-nitrosylated Parkin, DJ-1 and PINK1 on the pathogenesis of Parkinson's disease

Archives of biochemistry and biophysics, 2021-06, Vol.704, p.108869-108869, Article 108869

2021

Volltextzugriff (PDF)

Evaluation of the PREDIGT score’s performance in identifying newly diagnosed Parkinson’s patients without motor examination

NPJ Parkinson's Disease, 2022-07, Vol.8 (1), p.94-94, Article 94

2022

Volltextzugriff (PDF)

Parkinson disease, 10 years after its genetic revolution: multiple clues to a complex disorder

Neurology, 2007-11, Vol.69 (22), p.2093

2007

Volltextzugriff (PDF)

1 – 25 von 145

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(139)
Mit Volltextzugriff
(131)

Publikationsform

Artikel
(142)
Buchkapitel
(3)

Sprache

Englisch
(145)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study

Multiple system atrophy: A primary oligodendrogliopathy

Alpha-synuclein in the appendiceal mucosa of neurologically intact subjects

CNS expression of glucocerebrosidase corrects α-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy

Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders

Deciphering the role of heterozygous mutations in genes associated with parkinsonism

Parkin-Dependent Degradation of the F-Box Protein Fbw7β Promotes Neuronal Survival in Response to Oxidative Stress by Stabilizing Mcl-1

Parkinson’s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures

Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson's disease

Molecular markers of early Parkinson's disease based on gene expression in blood

GATA transcription factors directly regulate the Parkinson's disease-linked gene α-synuclein

Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo

Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker Initiative

Genetic and pharmacological reduction of CDK14 mitigates synucleinopathy

DMS as an orthogonal separation to LC/ESI/MS/MS for quantifying isomeric cerebrosides in plasma and cerebrospinal fluid[S]

Progressive dopaminergic cell loss with unilateral-to-bilateral progression in a genetic model of Parkinson disease

Who Ever Said It Would Be Easy? Reflecting on Two Clinical Trials Targeting α‐Synuclein

Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19

A First Tetraplex Assay for the Simultaneous Quantification of Total α-Synuclein, Tau, β-Amyloid42 and DJ-1 in Human Cerebrospinal Fluid

effects of oxidative stress on parkin and other E3 ligases

Unraveling the assembloid: Real-time monitoring of dopaminergic neurites in an inter-organoid pathway connecting midbrain and striatal regions

Target‐Specific Strategies to Modify the Course of Parkinson's: Is Iron Chelation Safe?

Neurodegeneration: Impact of S-nitrosylated Parkin, DJ-1 and PINK1 on the pathogenesis of Parkinson's disease

Evaluation of the PREDIGT score’s performance in identifying newly diagnosed Parkinson’s patients without motor examination

Parkinson disease, 10 years after its genetic revolution: multiple clues to a complex disorder

Suchergebnisse filtern